Literature DB >> 1429807

Growth hormone and cortisol secretion in patients with burn injury.

M K Jeffries1, M L Vance.   

Abstract

A prospective study of growth hormone, insulin-like growth factor (IGF-1), and cortisol secretion was undertaken in six adults with burn injury. Serum concentrations of growth hormone and IGF-1 were low in all patients during the first 2 weeks of hospitalization. The mean growth hormone level was 4.35 +/- 0.83 micrograms/L on day 1 and 1.70 +/- 0.50 micrograms/L on day 13. The mean serum concentration of IGF-1, which reflects overall growth hormone secretion, was 0.43 +/- 0.09 U/ml on day 1 and 0.61 +/- 0.11 U/ml on day 13; these values are distinctly low. After 3 to 4 weeks, IGF-1 concentrations increased to the mid-normal range, whereas growth hormone values did not change. Morning plasma cortisol concentrations were modestly elevated; however, urine free cortisol concentrations, which reflect total cortisol secretion, were elevated 2 to 28 times above normal values at the time of admission (mean, 443.5 +/- 323.7 nmol/L). Urinary free cortisol concentrations remained elevated after 2 weeks (mean, 230.5 +/- 94.5 nmol/L). Patients with burn injury have inappropriately low growth hormone secretion and IGF-1 production in spite of the stress of the injury and more than adequate nutritional therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429807     DOI: 10.1097/00004630-199207000-00001

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  14 in total

1.  Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?

Authors:  G Pittoni; G Gallioi; M Zanello; L Gianotti; M F Boghen; S Colombo; F Broglio; C Santoro; G Davià; M G Papini; S Destefanis; F Minuto; C Miola; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

2.  Puerarin alleviates burn-related procedural pain mediated by P2X(3) receptors.

Authors:  Xin Li; Jun Zhang; Yun Gao; Yang Yang; Changshui Xu; Guilin Li; Guanghua Guo; Shuangmei Liu; Jinyan Xie; Shangdong Liang
Journal:  Purinergic Signal       Date:  2011-07-22       Impact factor: 3.765

3.  Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions.

Authors:  L Gianotti; F Broglio; G Aimaretti; E Arvat; S Colombo; M Di Summa; G Gallioli; G Pittoni; E Sardo; M Stella; M Zanello; C Miola; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 4.  What, how, and how much should patients with burns be fed?

Authors:  Felicia N Williams; Ludwik K Branski; Marc G Jeschke; David N Herndon
Journal:  Surg Clin North Am       Date:  2011-06       Impact factor: 2.741

Review 5.  Postburn Hypermetabolism: Past, Present, and Future.

Authors:  Marc G Jeschke
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

6.  Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency.

Authors:  L Gianotti; M Stella; D Bollero; F Broglio; F Lanfranco; G Aimaretti; S Destefanis; M Casati; G Magliacani; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 7.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

8.  Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury.

Authors:  W G Cioffi; D C Gore; L W Rue; G Carrougher; H P Guler; W F McManus; B A Pruitt
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

9.  Urinary cortisol and catecholamine excretion after burn injury in children.

Authors:  William B Norbury; David N Herndon; Ludwik K Branski; David L Chinkes; Marc G Jeschke
Journal:  J Clin Endocrinol Metab       Date:  2008-01-22       Impact factor: 5.958

10.  Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn.

Authors:  Gerd G Gauglitz; David N Herndon; Gabriela A Kulp; Walter J Meyer; Marc G Jeschke
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.